SHOULD A RECENT EXPOSURE OF RESEARCHERS AT DUKE CAUSE US TO QUESTION GENETIC TESTING FOR TREATMENT DECISIONS? ELIZABETH TRACEY REPORTS
Gene testing used to help guide treatment decisions for people with lung cancer got a blow recently when biostatisticians exposed a researcher at Duke for spinning his research results, presumably with profit from genetic testing in mind. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says this shouldn't cause us to throw out all genetic testing to inform cancer treatment.
NELSON: No, I think that would be the wrong conclusion to reach. I think that these technologies are going to be very important very helpful, they've already revolutionized the care of breast cancer for the better. I think what it does mean is that we're going to have to be very vigilant that we're not generating the wrong conclusions, we're going to be very vigilant to make sure that corruption or something doesn't prevent us from using this technology appropriately. The people we need, the detectives if you will need to come from this world of handling large datasets and analyzing them for their statistical certainty. :32
At Johns Hopkins, I'm Elizabeth Tracey.